We are proud to announce that PhenoPath is now part of AmeriPath.

News & Info

Find out what’s happening near you.

Latest News

  • PhenoPath acquired by Quest Diagnostics

    Please read the attached letter for an important announcement regarding PhenoPath

    Read More »
  • Phenomena v21.1

    New FDA Approvals for PD-L1/PD-1 Targeted Therapies & Introducing the Combined Positive Score (CPS); New Assays MUC4 IHC and TFE3 (Xp11) FISH; Amyloid Analysis;...

    Read More »
  • Phenomena v20.2 (Fall 2017)

    PhenoPath newsletter featuring the latest on RAS gene testing, "double-hit" B cell lymphomas, and a new marker for small cell carcinoma of the ovary.... Read More »